Search Results

Framatome of France Secures First U.S. High-Assay Low-Enriched Uranium Nuclear Fuel Contract

French nuclear company Framatome announced that it has signed a commercial contract to supply one operating nuclear reactor in the United States with the world's first nuclear fuel with uranium-235 concentration higher than the industry standard of 5%, for use in replacing reactor fuel. Under the agreement, as part of the Advanced Fuel Management (AFM) program, Framatome will use AFM technology to supply higher-concentration fuel in batches starting in early 2028. The agreement includes the supply of a range of fuels to support long-term use of AFM fuel in the reactor, and includes additional fuel supply options for the future. The company did not disclose the name of the reactor that will use the fuel. Uranium-235...

2026-09-23

New Generation "Harmony System" and Other Technological Achievements Debut at the 23rd China-ASEAN Expo

At the five-day 23rd China-ASEAN Expo and China-ASEAN Business and Investment Summit, CGN showcased its innovative achievements in nuclear power, new energy, and digitalization under the theme "Smart Nuclear Powers Free Trade, Green Electricity Connects ASEAN." At the exhibition, CGN Digital Technology highlighted its independently developed Harmony System series products and their applications in the new energy sector, and used virtual reality technology to give visitors the opportunity to tour nuclear power plants. The Harmony System is hailed as the "nerve center" and "brain" of nuclear power plants. It is China's independently developed nuclear safety-class digital instrumentation and control system, and has now been widely applied to 34 nuclear power units nationwide, covering second- to fourth-generation nuclear power reactor types and technologies. Through the comprehensive iterative upgrading of the Harmony System, CGN Digital Technology has equipped it with a smarter, safer, and more economical "super intelligent brain," aiming to provide digital and intelligent empowerment for the full-cycle production and operation of nuclear power plants.

2026-09-22

Guoke Ion Makes Its Debut at AOCMP 2026, Domestic Ion Therapy Technology Draws Attention from Asia-Pacific Peers

From September 9 to 11, 2026, the 26th Asia-Oceania Congress of Medical Physics (AOCMP 2026) was held at the Busan Port International Exhibition & Convention Center (BPEX) in South Korea. Hosted by the Korean Society of Medical Physics (KSMP), this year's congress focused on innovative applications of cutting-edge technologies such as artificial intelligence and automation in the field of medical physics, and is a highly influential academic event in the Asia-Pacific region. Wang Xiaomin, Deputy General Manager of Guoke Ion, and Yang Wenjie, Assistant to the General Manager, led a delegation to attend the congress, actively carrying out academic exchanges and industry engagement. During the congress, the Guoke Ion team conducted technical presentations and exchanges through specialized seminars and a corporate exhibition booth. At the specialized seminar, the team systematically introduced the company's ion therapy equipment and its self-developed...

2026-09-22

Israel's nT-TaO Signs Memorandum of Understanding with US-based Orion to Explore Deployment of Compact Fusion Systems for Data Center Power Supply

Israeli fusion company nT-TaO and US nuclear energy development company Orion Nuclear Energy Corporation signed a memorandum of understanding (MoU) on September 21, 2026, to explore the deployment of nT-TaO's Compact Fusion systems at data centers and industrial facilities in the United States. The move is seen as a collaborative step forward in the commercialization of fusion technology. According to the memorandum, the cooperation will center on the commercialization of nT-TaO's compact fusion system, with key focuses including: identifying potential customers, evaluating site selection, and developing specific commercial projects. The system is designed to provide up to 20 ...

2026-09-22

South Korea Promotes K-Decommissioning Nuclear Power Plant Decommissioning Technology Overseas

At the 2026 Nuclear Facility Decommissioning Business Forum held on the 18th at the Westin Chosun Seoul, Seo Beom-kyung (서범경), Director of the Clean Nuclear Facility Technology Development Department at the Korea Atomic Energy Research Institute (KAERI), stated that given the limited scale of the domestic nuclear facility decommissioning market, it is necessary to turn attention to overseas markets. Seo Beom-kyung said that the scale of South Korea's domestic decommissioning market is limited, so attention must be directed overseas. This requires the establishment of international standards, as well as decommissioning methods that reduce environmental burden and plans for subsequent site utilization. At the same time, emphasis must be placed on verifying K-Decommissioning technology in practical applications to ensure its performance and safety. Although technologies achieved at the R&D stage may...

2026-09-22

Jiluntai's independently developed HER2-targeted diagnostic new drug has been approved for clinical trials, expected to facilitate precision treatment of breast cancer

Jiluntai Company, a nuclear medicine innovation enterprise invested and incubated by Baiyang Pharmaceutical Group, has recently made important progress. Its independently developed Class 1 chemical radioactive diagnostic new drug —— Technetium [⁹⁹ᵐTc] hydrazinonicotinamide dual-chain Ark peptide injection (⁹⁹ᵐTc‑HP‑Ark2), has received supplementary clinical trial application approval from the National Medical Products Administration (NMPA), which means the product will continue to undergo clinical trials, bringing new hope for precision subtyping and treatment of breast cancer. This product is a radioactive diagnostic agent for SPECT/CT imaging, intended for the differential diagnosis of HER2-positive breast cancer. HER2 is an important prognostic indicator for malignant tumors such as breast cancer...

2026-09-21

New Progress in Research on Microstructural Stability of High-Silicon Austenitic Steels for Lead-Cooled Fast Reactors

The lead-cooled fast reactor is an important reactor type in the fourth-generation nuclear energy system, and its structural materials need to withstand harsh service environments such as high temperature, irradiation, and liquid lead-bismuth corrosion over the long term. High-silicon austenitic stainless steel possesses excellent lead-bismuth corrosion resistance and is an important candidate structural material for core equipment such as the reactor vessel and internals of lead-cooled fast reactors. However, Si addition significantly alters the phase precipitation mechanism during high-temperature service and induces austenite decomposition, affecting the long-term microstructural stability of the material. Recently, the Special Alloys Research Department of the Institute of Metal Research, Chinese Academy of Sciences, in collaboration with the Department of Mechanical Engineering of The Hong Kong Polytechnic University, building on prior work that revealed Si-induced austenite decomposition behavior in high-silicon austenitic steels and the resulting mechanical...

2026-09-21

US Delivers Cold War-Era Reactor Molten Salt Coolant to Texas Nuclear Innovation Project

The U.S. nuclear energy sector has recently seen a landmark cross-generational collaboration. The U.S. Department of Energy (DOE)'s Oak Ridge National Laboratory (ORNL) has formally delivered over 2 metric tons of FLiBe molten salt to Natura Resources, a nuclear startup headquartered in Abilene, Texas. This batch of molten salt once served as the coolant for the historic Molten Salt Reactor Experiment (MSRE) during the Cold War, and after decades in storage, it has been reactivated to support the research, development, and deployment of fourth-generation nuclear reactor technology. The delivered FLiBe molten salt is a mixture of lithium fluoride and beryllium fluoride, and its distinctive feature is that the lithium-7 (Li-7) isotope abundance within it reaches as high as 99.99%...

2026-09-20

ACRA Rating Agency Confirms Rosatom's ESG Rating at ESG-2 (AA+) Level

On September 18, 2026, according to the latest assessment results, ACRA Rating Agency confirmed that the ESG rating of Rosatom State Atomic Energy Corporation (Rosatom) remains at the ESG-2 (AA+) level, which represents the company's exceptionally high evaluation in the areas of environmental protection, social responsibility, and corporate governance. This also marks the fourth consecutive year that the agency has confirmed this exceptionally high rating for Rosatom. At the same time, the rating agency assigned a stable outlook to the group, meaning that its ESG rating is highly likely to remain stable over the next 12 to 18 months. To carry out the data collection work for this ESG rating, six core divisions under Rosatom actively participated, including the mining division, the power division, ...

2026-09-20

X-energy and Centrica Partner to Launch the UK's First Xe-100 Advanced Modular Nuclear Power Plant Project

The UK government has approved the regulatory assessment phase for advanced reactors, marking an important step forward for the construction of a new generation of nuclear power plants. X-energy and Centrica are collaborating to build a new generation of nuclear power plants in the UK using the Xe-100 advanced modular reactor, with the first project sited at Hartlepool. This collaboration is of great significance, marking substantial progress on the UK's nuclear energy development path and laying the foundation for broader nuclear power plant construction in the future. Alistair Black, Vice President and UK Market Lead at X-energy, emphasized that since signing the cooperation agreement with Centrica, both parties have been working together on the first project at Hartlepool...

2026-09-18

Microstructure Imaging's MICSI-PET Software Receives FDA Clearance to Enhance Neurological PET Imaging Using MRI

Microstructure Imaging's software platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The platform is designed to enhance neurological positron emission tomography (PET) images using structural magnetic resonance imaging (MRI). The software, called MICSI-PET, can denoise and super-resolve PET images using MRI guidance while preserving quantitative PET information. It supports PET exams for amyloid, Tau, and FDG (fluorodeoxyglucose), and can provide automated Centiloid measurements for amyloid imaging and CenTauR measurements for Tau imaging....

2026-09-18

Professor Yan Lixin's Research Group in the Department of Engineering Physics at Tsinghua University Collaborates to Achieve a Beyond-Megawatt Average Power Laser Optical Enhancement Cavity

Recently, the research group of Professor Yan Lixin from the Department of Engineering Physics at Tsinghua University, in collaboration with the team of Professor Fabian Zomer from IJCLab at Université Paris-Saclay, France, published important progress in the field of high-finesse optical enhancement cavities. The research team achieved a four-mirror bow-tie optical cavity with an average laser power exceeding 1 megawatt and its stable operation at the Tsinghua University Accelerator Laboratory, with a maximum intracavity average power of 1.15 MW, while maintaining an excellent Gaussian fundamental mode. This is the first published work internationally on an optical enhancement cavity with an intracavity average laser power reaching the megawatt level, which will lay a solid foundation for important applications such as the development of steady-state microbunching (SSMB) extreme ultraviolet light sources, quantum electrodynamics (QED) vacuum nonlinearity detection, ion beam photoneutralization for magnetic confinement fusion, and the development of future inertial confinement fusion reactors.

2026-09-18

The SM-1 Nuclear Power Plant at Fort Belvoir, United States, Has Completed All On-Site Decommissioning and Dismantlement Work

The Baltimore District of the U.S. Army Corps of Engineers recently announced that the SM-1 nuclear power plant at Fort Belvoir, Virginia, has completed all on-site decommissioning and dismantlement work. On September 9, 2026, at the closing ceremony of the SM-1 nuclear power plant decommissioning and dismantlement project held at Fort Belvoir, Virginia, leaders from the U.S. Army, the U.S. Army Corps of Engineers, the Fort Belvoir Garrison, and the project contractor posed for a photo with the original 1957 building sign of the SM-1 nuclear power plant. The ceremony marked the successful completion of all on-site work related to the decommissioning and dismantlement of the nuclear power plant. The U.S. Army's SM-1 (Stationary Medium Power Reactor Prototype No. 1) is a 2-megawatt experimental small...

2026-09-17

South Korea Plans to Open Up "Direct Purchase" of Nuclear Power: A Low-Cost Pathway for Industrial Decarbonization, or a New Challenge for the Electricity Market?

2026-09-17

ZAP-X Gyroscopic Stereotactic Radiosurgery Platform Makes Its Australian Debut, Expanding Precision Non-Invasive Brain Radiotherapy

ZAP Surgical, the global leader in non-invasive robotic brain surgery, recently announced that GenesisCare will become the first cancer care provider in Australia to introduce the ZAP-X Gyroscopic Radiosurgery platform. Installation of the device is scheduled to begin this month at the GenesisCare center located at St Vincent's Hospital Sydney in New South Wales, with the first patients expected to receive treatment before the end of this year. The introduction of the ZAP-X platform will significantly enhance GenesisCare's neuro-oncology diagnostic and treatment capabilities in Sydney, providing it with dedicated stereotactic radiosurgery (SRS) services. Prior to this, patients receiving S...

2026-09-17